Free Trial

Medical Properties Trust (NYSE:MPT) Hits New 1-Year Low - Here's What Happened

Medical Properties Trust logo with Real Estate background
Image from MarketBeat Media, LLC.

Key Points

  • Medical Properties Trust fell to a new 52-week low, trading as low as $1.92, down from its previous close of $2.05.
  • Recent analyst actions were broadly negative: MarketBeat reports a “Strong Sell” consensus and an average price target of $2.68, with firms cutting ratings or targets.
  • The company’s latest quarterly earnings missed estimates, reporting $0.11 per share versus $0.13 expected. Its quarterly dividend of $0.09 equates to a 19% annualized yield at the reported share price.
  • Interested in Medical Properties Trust? Here are five stocks we like better.

Medical Properties Trust, Inc. (NYSE:MPT - Get Free Report) reached a new 52-week low during mid-day trading on Thursday. The stock traded as low as $1.92 and last traded at $1.93, with a volume of 2,948,831 shares. The stock had previously closed at $2.05.

Analyst Ratings Changes

A number of brokerages recently issued reports on MPT. BNP Paribas Exane downgraded Medical Properties Trust from an "outperform" rating to a "neutral" rating and set a $2.25 price target on the stock. in a report on Tuesday. Wells Fargo & Company cut their price objective on Medical Properties Trust from $5.00 to $3.80 and set an "underweight" rating on the stock in a research report on Tuesday, September 1st. Royal Bank Of Canada cut Medical Properties Trust from a "sector perform" rating to an "underperform" rating and reduced their target price for the company from $4.50 to $2.00 in a research note on Friday, October 30th. Finally, Weiss Ratings cut Medical Properties Trust from a "sell (d+)" rating to a "sell (d)" rating in a research note on Tuesday, August 18th. One analyst has rated the stock with a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Strong Sell" and an average price target of $2.68.

Check Out Our Latest Stock Report on Medical Properties Trust

Medical Properties Trust Trading Down 7.8%

The company has a market capitalization of $1.13 billion, a P/E ratio of 4.61 and a beta of 1.50. The company has a debt-to-equity ratio of 2.00, a current ratio of 3.92 and a quick ratio of 3.12. The stock's 50 day moving average is $3.30 and its 200-day moving average is $4.31.

Medical Properties Trust (NYSE:MPT - Get Free Report) last released its quarterly earnings results on Thursday, October 29th. The company reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.13 by ($0.02). The firm had revenue of $250.14 million for the quarter. Medical Properties Trust had a net margin of 24.14% and a return on equity of 5.45%. The business's revenue for the quarter was up 5.3% compared to the same quarter last year. As a group, equities research analysts anticipate that Medical Properties Trust, Inc. will post 0.53 earnings per share for the current year.

Medical Properties Trust Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, October 8th. Stockholders of record on Thursday, September 10th were given a $0.09 dividend. The ex-dividend date of this dividend was Thursday, September 10th. This represents a $0.36 dividend on an annualized basis and a dividend yield of 19.0%. Medical Properties Trust's dividend payout ratio is currently 87.80%.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the business. Amundi boosted its holdings in shares of Medical Properties Trust by 1.6% in the second quarter. Amundi now owns 388,683 shares of the company's stock worth $1,796,000 after buying an additional 6,252 shares during the last quarter. Continuum Advisory LLC purchased a new stake in Medical Properties Trust during the second quarter valued at approximately $31,000. CoreCap Advisors LLC purchased a new stake in Medical Properties Trust during the third quarter valued at approximately $27,000. Nykredit A S purchased a new stake in Medical Properties Trust during the second quarter valued at approximately $41,000. Finally, NFSG Corp purchased a new stake in Medical Properties Trust during the third quarter valued at approximately $34,000. 71.79% of the stock is owned by hedge funds and other institutional investors.

Medical Properties Trust Company Profile

(Get Free Report)

Medical Properties Trust, Inc is a healthcare-focused real estate investment trust (REIT) that owns and invests in healthcare facilities. Its portfolio has historically included hospitals, inpatient rehabilitation facilities, long-term acute-care hospitals, behavioral health facilities and other properties used by healthcare providers.

Founded in 2003 and headquartered in Birmingham, Alabama, the company primarily generates income by leasing properties to healthcare operators under long-term agreements.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Medical Properties Trust Right Now?

Before you consider Medical Properties Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medical Properties Trust wasn't on the list.

While Medical Properties Trust currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines